1. Silman AJ. Scleroderma—demographics and survival. J Rheumatol 1997;34(suppl 48):58-61.

2. Medsger TA, Masi AT. Epidemiology of systemic sclerosis (scleroderma). Ann Int Med 1971 ;74:7 !4— 721.

3. Maricq HR, Weinrich MC, Keil JE et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthrit Rheum 1989;32:998-1006.

4. Wigley RD, Borman B. Medical geography and the etiology of the rare connective tissue. Soc Sci Med 1980;14D:175-183.

5. Steen V, Conte C, Santoro D et al. Twenty year incidence survey of systemic sclerosis. Arthrit Rheum 1988;32(suppl):557.

6. Altman RD, Medsger TA, Bloch DA, Michel BA. Predictors of survival in systemic sclerosis (scleroderma). Arthrit Rheum 1991;34:403-413.

7. Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 1998;37:750-755.

8. Rosenthal AK, McLaughlin JK, Linet MS, Persson I. Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 1993;52:531-533.

9. Roumm AD, Medsger TA. Cancer and systemic sclerosis: an epidemiologic study. Arthrit Rheum 1985;28:1336-1340.

10. Duncan SC, Winkelman RK. Cancer and scleroderma. Arch Dermatol 1979;115:950-955.

11. Doyle JA, Connolly SM, Haogland HC. Hematologic disease in scleroderma syndromes. Arch Dermatol Venereol 1985;65:521-525.

12. Pulik, Teillet-Thiebaud F, Mahe A, Teillet F. Association lymphome non-Hodgkinien et sclerodermic. Presse Med 1991;20:1513-1514.

13. Katzka D, Reynolds JC, Saul SH, et al. Barrette's metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med 1987;82:46-52.

14. Talbott JH, Barrocas M. Progressive systemic sclerosis and malignancy, pulmonary and non-pulmonary, Medicine (Baltimore) 1979;58:182-207.

15. Lee P, Alderdice C, Wilkinson S, et al. Malignancy in progressive systemic sclerosis-association with breast carcinoma. J Rheumatol 1983;10:665-666.

16. Nishioka K, Katayama I, Kondo H, et al. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis. J Dermatol 1996;23:677-682.

17. LeRoy EC, Smith EA, Kahalch MB, et al. A strategy for determining the pathogenesis of systemic sclerosis: is transforming growth factor beta the answer? Arthrit Rheum 1989;32:817-824.

18. Allen-Hoffman BL, Crankshaw CL, Mosher DF. Transforming growth factor beta increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts. Mol Cell Biol 1988;8:4234-4242.

19. Abu-Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthrit Rheum 1993;36:460-464.

© 2000 Elsevier Science B. V. All rights reserved. Cancer and Autoimmunity Y. Shoenfeld and M. E. Gershwin, editors

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment